163 related articles for article (PubMed ID: 7604004)
1. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic conversion.
Li D; Noyes I; Shuler C; Milo GE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6409-13. PubMed ID: 7604004
[TBL] [Abstract][Full Text] [Related]
2. Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene.
Li D; Yan H; Chen J; Casto BC; Theil KS; Milo GE
Carcinogenesis; 1996 Aug; 17(8):1751-5. PubMed ID: 8761437
[TBL] [Abstract][Full Text] [Related]
3. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
[TBL] [Abstract][Full Text] [Related]
4. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
[TBL] [Abstract][Full Text] [Related]
5. Changes in levels of normal ML-1 gene transcripts associated with the conversion of human nontumorigenic to tumorigenic phenotypes.
Sun XL; Li D; Fang J; Noyes I; Casto B; Theil K; Shuler C; Milo GE
Gene Expr; 1999; 8(2):129-39. PubMed ID: 10551800
[TBL] [Abstract][Full Text] [Related]
6. Malignant conversion of chemically transformed normal human cells.
Milo GE; Li D; Casto BC; Theil K; Shuler C; Noyes I; Chen J
Proc Natl Acad Sci U S A; 1996 May; 93(11):5229-34. PubMed ID: 8643558
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus growth-transformed cells are converted to malignancy following transfection of a 1.3-kb CATR1 antisense construct independent of a change in the level of c-myc expression followed by a 8;14 chromosomal translocation.
Li D; Sun XL; Casto B; Fang J; Theil K; Glaser R; Milo G
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4894-9. PubMed ID: 9560199
[TBL] [Abstract][Full Text] [Related]
8. Noncorrelative c-myc and ras oncogene expression in squamous cell carcinoma cells with tumorigenic potential.
Shuler C; Kurian P; French BT; Noyes I; Sital N; Hollering J; Trewyn RW; Schuller D; Milo GE
Teratog Carcinog Mutagen; 1990; 10(1):53-65. PubMed ID: 1693449
[TBL] [Abstract][Full Text] [Related]
9. TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines.
Kasukabe T; Okabe-Kado J; Honma Y
Blood; 1997 Apr; 89(8):2975-85. PubMed ID: 9108418
[TBL] [Abstract][Full Text] [Related]
10. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
11. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
Lichy JH; Modi WS; Seuanez HN; Howley PM
Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
[TBL] [Abstract][Full Text] [Related]
12. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response.
Patel S; Wang FH; Whiteside TL; Kasid U
Oral Oncol; 1997 May; 33(3):197-203. PubMed ID: 9307729
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of three isoforms of OS-9 cDNA and expression of the OS-9 gene in various human tumor cell lines.
Kimura Y; Nakazawa M; Yamada M
J Biochem; 1998 May; 123(5):876-82. PubMed ID: 9562620
[TBL] [Abstract][Full Text] [Related]
14. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a pituitary tumor-transforming gene (PTTG).
Pei L; Melmed S
Mol Endocrinol; 1997 Apr; 11(4):433-41. PubMed ID: 9092795
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
17. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.
Su ZZ; Lin J; Shen R; Fisher PE; Goldstein NI; Fisher PB
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7252-7. PubMed ID: 8692978
[TBL] [Abstract][Full Text] [Related]
18. Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta.
Tannehill-Gregg S; Kergosien E; Rosol TJ
In Vitro Cell Dev Biol Anim; 2001; 37(10):676-83. PubMed ID: 11776973
[TBL] [Abstract][Full Text] [Related]
19. Metastatic conversion of chemically transformed human cells.
Sun XL; Li D; Fang J; Casto B; Noyes I; Milo GE
Gene Expr; 1999; 8(5-6):327-39. PubMed ID: 10947081
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of keratin 5 gene in non-tumorigenic and tumorigenic rat bladder cell lines.
Nan L; Kawamata H; Tan X; Kameyama S; Oyasu R
Cancer Lett; 1993 Dec; 75(2):87-93. PubMed ID: 7507402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
